We proudly recognize Simon Jackson and Chadwick (Chad) King, recipients of Amgen’s prestigious George B. Rathmann Award for Scientific Excellence, for their groundbreaking work unlocking the potential of PCSK9 biology in LDL regulation and cardiovascular disease. Their journey from decoding the complexities of human genetics to delivering life-changing medicine reflects the very essence of our mission: to serve patients. 🔗 Learn more about their inspiring story: https://amgen.ly/42oSlSS
Congrats 🎉 Your discovery of key mechanistic aspects of PCSK9 biology and development of this therapeutic have been a real game changer for atherosclerosis patients.
Congrats ! So very well deserved, simply the best !
You guys are doing amazing!!!
Congratulations!
Congrats Simon and Chad - this has made such a huge impact on patient lives!
Congratulations!
Congratulations on having your breakthrough work recognized Simon & Chad! 👏🏽👏🏽
Congratulations on receiving Amgen’s prestigious George B. Rathmann Award for Scientific Excellence!
Congratulations Simon and Chad! Well done gents. 👏 Truly groundbreaking work that will change lives.
Executive Director Plant Manager of Manufacturing Amgen
2moWell deserved recognition for amazing work